Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-19

Clinical Trial Update: Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sugammadex and neostigmine for reversal of neuromuscular blockade in thoracic surgery patients has completed with results posted in 2020…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Neuromuscular Blockade | Phase 4 | Status: COMPLETED | Results posted: 2020-02-19